PQQ (Pyrroloquinoline Quinone) 用于 氧化应激(心血管)
C 证据 来自小型研究的证据有限,但存在一些积极信号。Small RCT showed LDL and CRP reduction. Exceptional antioxidant potency. Cardiovascular-specific human data is very limited despite strong preclinical evidence.
结论
Small RCT showed LDL and CRP reduction. Exceptional antioxidant potency. Cardiovascular-specific human data is very limited despite strong preclinical evidence.
Key Study Findings
研究人群: General/aging population
Key Statistics
2
研究数量
100
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 10-20 mg/day
- cardiovascularsupport:
- 20 mg/day
上限: Not formally established; up to 60 mg/day used in short-term studies
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
最佳服用时间: With or without food
Safety & Side Effects
已报告的副作用
- ⚠ Generally well-tolerated
- ⚠ Mild headache (rare)
- ⚠ Mild gastrointestinal discomfort (rare)
已知相互作用
- ● May enhance effects of CoQ10 (synergistic mitochondrial support)
- ● Theoretical interaction with anticoagulants
可耐受最高摄入量: Not formally established; up to 60 mg/day used in short-term studies
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does PQQ (Pyrroloquinoline Quinone) help with 氧化应激(心血管)?
How much PQQ (Pyrroloquinoline Quinone) should I take for 氧化应激(心血管)?
Are there side effects of PQQ (Pyrroloquinoline Quinone)?
How strong is the evidence for PQQ (Pyrroloquinoline Quinone) and 氧化应激(心血管)?
Related Evidence
其他成分用于 氧化应激(心血管)
PQQ (Pyrroloquinoline Quinone) 用于其他健康状况
References
- [1] James J DiNicolantonio et al.. Open Heart. 2022. Nutraceutical activation of Sirt1: a review. doi:10.1136/openhrt-2022-002171 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。